(PCRX) Pacira BioSciences - Performance -16% in 12m
Compare PCRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-47.64%
#94 in Group
Rel. Strength
38.46%
#4897 in Universe
Total Return 12m
-15.99%
#75 in Group
Total Return 5y
-43.64%
#89 in Group
P/E -
(?) Percentile in Group
P/E Forward 9.83
24th Percentile in Group
PEG -3.83
2th Percentile in Group
FCF Yield 13.4%
88th Percentile in Group
12m Total Return: PCRX (-16%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
| LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
| NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
| NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
| SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
| SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
| IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
| SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: PCRX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PCRX
| Total Return (including Dividends) | PCRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -5.18% | 0.87% | 13.81% |
| 3 Months | -4.56% | -7.96% | -6.30% |
| 12 Months | -15.99% | -4.06% | 10.65% |
| 5 Years | -43.64% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | PCRX | XLV | S&P 500 |
| 1 Month | 41.9% | -8.1% | 83% |
| 3 Months | 9.30% | -75.3% | -75.3% |
| 12 Months | 6.0% | -28.8% | 50.1% |
| 5 Years | -85.4% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #65 | -6.0% | -16.7% |
| 3 Month | #56 | 3.69% | 1.85% |
| 12 Month | #76 | -12.4% | -24.1% |
| 5 Years | #92 | -60.7% | -72.9% |
FAQs
Does PCRX Pacira BioSciences outperforms the market?
No,
over the last 12 months PCRX made -15.99%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months PCRX made -4.56%, while XLV made -7.96%.
Over the last 3 months PCRX made -4.56%, while XLV made -7.96%.
Performance Comparison PCRX vs Indeces and Sectors
PCRX vs. Indices PCRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.06% | -19.0% | 49.4% | -26.6% |
| US NASDAQ 100 | QQQ | -8.25% | -22.5% | 49.2% | -27.6% |
| US Dow Jones Industrial 30 | DIA | -8.47% | -15.2% | 49.7% | -23.7% |
| German DAX 40 | DAX | -8.04% | -20.1% | 23.2% | -41.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.2% | -17.0% | 48.7% | -23.4% |
| Hongkong Hang Seng | HSI | -11.2% | -25.1% | 41.1% | -29.7% |
| India NIFTY 50 | INDA | -3.14% | -10.0% | 49.0% | -15.8% |
| Brasil Bovespa | EWZ | -9.11% | -22.4% | 40.7% | -7.66% |
PCRX vs. Sectors PCRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.70% | -18.6% | 42.4% | -37.6% |
| Consumer Discretionary | XLY | -8.44% | -19.4% | 50.4% | -30.3% |
| Consumer Staples | XLP | -7.20% | -11.8% | 42.5% | -25.1% |
| Energy | XLE | -7.88% | -11.9% | 56.0% | -6.53% |
| Financial | XLF | -9.16% | -18.7% | 42.3% | -38.4% |
| Health Care | XLV | -5.05% | -6.05% | 54.4% | -11.9% |
| Industrial | XLI | -9.75% | -22.0% | 48.0% | -27.0% |
| Materials | XLB | -7.86% | -18.7% | 54.3% | -10.8% |
| Real Estate | XLRE | -6.74% | -16.7% | 48.7% | -31.4% |
| Technology | XLK | -9.14% | -26.4% | 52.3% | -23.1% |
| Utilities | XLU | -8.11% | -14.8% | 41.8% | -33.5% |
| Aerospace & Defense | XAR | -10.0% | -26.3% | 37.9% | -43.3% |
| Biotech | XBI | -1.47% | -17.0% | 69.6% | -3.70% |
| Homebuilder | XHB | -8.53% | -16.7% | 62.6% | -8.44% |
| Retail | XRT | -9.96% | -19.8% | 53.7% | -14.5% |